{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:25:55Z","timestamp":1785266755125,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Approximately 20\u201350% of patients develop biochemical recurrence (BCR) of prostate cancer within 10 years following radical prostatectomy (RP). The accurate identification of recurrent disease is crucial for guiding salvage treatment decisions. While multiparametric MRI (mpMRI) and prostate-specific membrane antigen positron emission tomography\/computed tomography (PSMA PET\/CT) are both utilized for detecting local recurrence, their combined diagnostic benefits remain unclear. This study seeks to evaluate the diagnostic performance of both modalities alone and in conjunction for detecting local recurrence following RP in patients with BCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective single-institution analysis included 37 post-RP patients with BCR who received mpMRI and PSMA PET\/CT. Five board-certified radiologists reviewed images in three phases: mpMRI only, PSMA PET\/CT only, and both modalities combined. Multidisciplinary tumor board consensus served as the reference standard. Diagnostic performance, inter-reader agreement, and radiologist confidence with each modality was examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MpMRI outperformed PSMA PET\/CT, yielding a higher sensitivity (73.0% vs. 65.2%) and specificity (77.1% vs. 75.7%). Interpretation of mpMRI and PSMA PET\/CT together achieved the highest diagnostic accuracy (77.8%), representing a statistically-significant increase over PSMA PET\/CT (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.026) but a non-statistically-significant increase over mpMRI (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.441). Combined imaging also resulted in greater specificity (90.0%) and inter-rater reliability (\u03ba\u2009=\u20090.622). However, in some cases performance decreased with both modalities due to interpretive pitfalls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While mpMRI remains the preferred imaging modality for post-RP local recurrence surveillance, the integration of PSMA PET\/CT may lead to improved specificity and inter-rater reliability. However, radiologists must understand each modality\u2019s limitations to avoid interpretive pitfalls.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00261-025-05256-5","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T07:50:47Z","timestamp":1762588247000},"page":"3010-3021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic performance of PSMA PET\/CT, multiparametric MRI, and combined imaging for local prostate cancer recurrence after radical prostatectomy"],"prefix":"10.1007","volume":"51","author":[{"given":"Michael","family":"Phillipi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Choung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Anavim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Glavis-Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Imanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Seyedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Uchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Daneshvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roozbeh","family":"Houshyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"key":"5256_CR1","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND, Tannock I, N\u2019Dow J, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet 2024; 403:1683\u20131722","journal-title":"Lancet"},{"key":"5256_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/RMR.0000000000000088","volume":"25","author":"FV Mertan","year":"2016","unstructured":"Mertan FV, Greer MD, Borofsky S, et al. Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer. Top Magn Reson Imaging 2016; 25:139\u2013147","journal-title":"Top Magn Reson Imaging"},{"key":"5256_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41391-023-00712-z","volume":"27","author":"ND Shore","year":"2024","unstructured":"Shore ND, Moul JW, Pienta KJ, Czernin J, King MT, Freedland SJ. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification. Prostate Cancer and Prostatic Diseases 2024; 27:192\u2013201","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"5256_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/JU.0000000000003892","volume":"211","author":"TM Morgan","year":"2024","unstructured":"Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage Therapy for Prostate Cancer: AUA\/ASTRO\/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy. Journal of Urology 2024; 211:509\u2013517","journal-title":"Journal of Urology"},{"key":"5256_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/j.semnuclmed.2023.07.002","volume":"54","author":"H Duan","year":"2024","unstructured":"Duan H, Iagaru A. PSMA PET for Detection of Recurrence. Semin Nucl Med 2024; 54:77\u201386","journal-title":"Semin Nucl Med"},{"key":"5256_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4103\/UA.UA_170_20","volume":"15","author":"S Hill","year":"2023","unstructured":"Hill S, Kassam F, Verma S, Sidana A. Traditional and novel imaging modalities for advanced prostate cancer: A critical review. Urol Ann 2023; 15:249\u2013255","journal-title":"Urol Ann"},{"key":"5256_CR7","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2214\/AJR.09.2527","volume":"192","author":"B Turkbey","year":"2009","unstructured":"Turkbey B, Albert PS, Kurdziel K, Choyke PL. Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol 2009; 192:1471\u20131480","journal-title":"AJR Am J Roentgenol"},{"key":"5256_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.rcl.2017.10.008","volume":"56","author":"S Gaur","year":"2018","unstructured":"Gaur S, Turkbey B. Prostate MR Imaging for Posttreatment Evaluation and Recurrence. Radiol Clin North Am 2018; 56:263\u2013275","journal-title":"Radiol Clin North Am"},{"key":"5256_CR9","doi-asserted-by":"crossref","unstructured":"Saule L, Radzina M, Liepa M, et al. Recurrent Prostate Cancer Diagnostics with (18)F-PSMA-1007 PET\/CT: A Systematic Review of the Current State. Diagnostics (Basel) 2022; 12","DOI":"10.3390\/diagnostics12123176"},{"key":"5256_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.diii.2012.01.012","volume":"93","author":"O Rouvi\u00e8re","year":"2012","unstructured":"Rouvi\u00e8re O. Imaging techniques for local recurrence of prostate cancer: for whom, why and how? Diagn Interv Imaging 2012; 93:279\u2013290","journal-title":"Diagn Interv Imaging"},{"key":"5256_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s11912-025-01682-2","volume":"27","author":"L Wang","year":"2025","unstructured":"Wang L, Wang L, Wang X, Wu D. The Evolving Role of PSMA-PET\/CT in Prostate Cancer Management: an Umbrella Review of Diagnostic Restaging, Therapeutic Redirection, and Survival Impact. Curr Oncol Rep 2025; 27:774\u2013787","journal-title":"Curr Oncol Rep"},{"key":"5256_CR12","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00259-016-3578-z","volume":"44","author":"C Uprimny","year":"2017","unstructured":"Uprimny C, Kroiss AS, Decristoforo C, et al. Early dynamic imaging in (68)Ga- PSMA-11 PET\/CT allows discrimination of urinary bladder activity and prostate cancer lesions. Eur J Nucl Med Mol Imaging 2017; 44:765\u2013775","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5256_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s00259-016-3594-z","volume":"44","author":"MT Freitag","year":"2017","unstructured":"Freitag MT, Radtke JP, Afshar-Oromieh A, et al. Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in (68)Ga-PSMA-11-PET of PET\/CT and PET\/MRI: comparison with mpMRI integrated in simultaneous PET\/MRI. Eur J Nucl Med Mol Imaging 2017; 44:776\u2013787","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5256_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0022-5347(17)36208-0","volume":"149","author":"TA Stamey","year":"1993","unstructured":"Stamey TA, Graves HC, Wehner N, Ferrari M, Freiha FS. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J Urol 1993; 149:787\u2013792","journal-title":"J Urol"},{"key":"5256_CR15","doi-asserted-by":"publisher","first-page":"e230112","DOI":"10.1148\/rg.230112","volume":"43","author":"MO Awiwi","year":"2023","unstructured":"Awiwi MO, Gjoni M, Vikram R, et al. MRI and PSMA PET\/CT of Biochemical Recurrence of Prostate Cancer. RadioGraphics 2023; 43:e230112","journal-title":"RadioGraphics"},{"key":"5256_CR16","first-page":"106","volume":"10","author":"M Radzina","year":"2020","unstructured":"Radzina M, Tirane M, Roznere L, et al. Accuracy of (68)Ga-PSMA-11 PET\/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer. Am J Nucl Med Mol Imaging 2020; 10:106\u2013118","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"5256_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jfma.2020.07.029","volume":"120","author":"J-R Tseng","year":"2021","unstructured":"Tseng J-R, Yu K-J, Liu F-Y, et al. Comparison between 68Ga-PSMA-11 PET\/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy. Journal of the Formosan Medical Association 2021; 120:688\u2013696","journal-title":"Journal of the Formosan Medical Association"},{"key":"5256_CR18","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.3390\/diagnostics12112594","volume":"12","author":"AD Combes","year":"2022","unstructured":"Combes AD, Palma CA, Calopedos R, et al. PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer. Diagnostics 2022; 12:2594","journal-title":"Diagnostics"},{"key":"5256_CR19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.2967\/jnumed.115.154153","volume":"56","author":"M Eiber","year":"2015","unstructured":"Eiber M, Maurer T, Souvatzoglou M, et al. Evaluation of Hybrid \u2076\u2078Ga-PSMA Ligand PET\/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy. J Nucl Med 2015; 56:668\u2013674","journal-title":"J Nucl Med"},{"key":"5256_CR20","doi-asserted-by":"crossref","unstructured":"Ciccarese F, Corcioni B, Bianchi L, et al. Clinical Application of the New Prostate Imaging for Recurrence Reporting (PI-RR) Score Proposed to Evaluate the Local Recurrence of Prostate Cancer after Radical Prostatectomy. Cancers (Basel) 2022; 14","DOI":"10.3390\/cancers14194725"},{"key":"5256_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2967\/jnumed.119.234187","volume":"61","author":"J Kuten","year":"2020","unstructured":"Kuten J, Fahoum I, Savin Z, et al. Head-to-Head Comparison of (68)Ga-PSMA-11 with (18)F-PSMA-1007 PET\/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard. J Nucl Med 2020; 61:527\u2013532","journal-title":"J Nucl Med"},{"key":"5256_CR22","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/RLU.0000000000004353","volume":"47","author":"P Sharma","year":"2022","unstructured":"Sharma P, Watts A, Singh H. Comparison of Internal Dosimetry of 18 F-PSMA-1007 and 68 Ga-PSMA-11-HBED-CC. Clin Nucl Med 2022; 47:948\u2013953","journal-title":"Clin Nucl Med"},{"key":"5256_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2214\/AJR.07.3032","volume":"190","author":"E Casciani","year":"2008","unstructured":"Casciani E, Polettini E, Carmenini E, et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. AJR Am J Roentgenol 2008; 190:1187\u20131192","journal-title":"AJR Am J Roentgenol"},{"key":"5256_CR24","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1007\/s00259-023-06332-y","volume":"50","author":"A Holzgreve","year":"2023","unstructured":"Holzgreve A, Unterrainer M, Calais J, et al. Is PSMA PET\/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial. Eur J Nucl Med Mol Imaging 2023; 50:3750\u20133754","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5256_CR25","doi-asserted-by":"publisher","first-page":"20210388","DOI":"10.1259\/bjr.20210388","volume":"94","author":"M Hosono","year":"2021","unstructured":"Hosono M, Takenaka M, Monzen H, Tamura M, Kudo M, Nishimura Y. Cumulative radiation doses from recurrent PET-CT examinations. Br J Radiol 2021; 94:20210388","journal-title":"Br J Radiol"},{"key":"5256_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1053\/j.semnuclmed.2024.05.007","volume":"54","author":"R Kazimierczyk","year":"2024","unstructured":"Kazimierczyk R, Kaminski KA, Nekolla SG. Cardiac PET\/MRI: Recent Developments and Future Aspects. Seminars in Nuclear Medicine 2024; 54:733\u2013746","journal-title":"Seminars in Nuclear Medicine"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05256-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05256-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05256-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:58:25Z","timestamp":1777021105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05256-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["5256"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05256-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7181604\/v1","asserted-by":"object"}]},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}